000002973 001__ 2973
000002973 005__ 20251031134742.0
000002973 0247_ $$2DOI$$a10.6083/M45Q4V1X
000002973 037__ $$aETD
000002973 245__ $$aThe association between gabapentin and suicidality in bipolar patients
000002973 269__ $$a2015
000002973 336__ $$aThesis
000002973 502__ $$bM.P.H.
000002973 520__ $$aGabapentin is an antiepileptic drug (AED) commonly used in the treatment of  bipolar disorder (BPD). In 2008, the US Food and Drug Administration (FDA) concluded that it is  associated with an increased risk of suicidality; however, published studies have arrived at  conflicting conclusions.  The objective of this work is to assess the association between the use of gabapentin and suicidality in a cohort  of adult patients diagnosed with bipolar disorder (BPD), and to determine if the risk is greater  relative to patients prescribed lithium.
000002973 540__ $$fCC BY
000002973 542__ $$fIn copyright - single owner
000002973 650__ $$aBipolar Disorder$$015590
000002973 650__ $$aSuicidal Ideation$$039477
000002973 650__ $$aGABA Agents$$031007
000002973 650__ $$aSelf-Injurious Behavior$$029356
000002973 650__ $$aLithium$$021576
000002973 650__ $$aSuicide, Attempted$$026556
000002973 691__ $$aSchool of Medicine$$041369
000002973 692__ $$aDepartment of Public Health and Preventive Medicine$$041444
000002973 7001_ $$aLeith, Wendy$$uOregon Health and Science University$$041354
000002973 7201_ $$aFreeman, Michael$$uOregon Health and Science University$$041354$$7Personal$$eAdvisor
000002973 8564_ $$95ec7637a-93f7-4134-9136-b5a78fc268b8$$s239217$$uhttps://digitalcollections.ohsu.edu/record/2973/files/3747_etd.pdf$$ePublic$$212f014016574fab193c7cce9cf253a55$$31
000002973 905__ $$a/rest/prod/0z/70/8w/52/0z708w525
000002973 909CO $$ooai:digitalcollections.ohsu.edu:2973$$pstudent-work
000002973 980__ $$aTheses and Dissertations